Assessment of Cell Cycle-related Elements p53, p21WAF1/Cip1, Cyclin D1 and PCNA in a Mixed Transitional Cell Carcinoma and Adenocarcinoma of the Renal Pelvis: A Case Report

Japanese Journal of Clinical Oncology

Volumn 28, Issue 3, 1998, Pages 227-232

  Lee, Chyi Chia R ^a   Masuda, Chikayoshi ^a   Yamamoto, Shinji ^a   Wanibuchi, Hideki ^a   Ikemoto, Shinichi ^a   Sugimura, Kazunobu ^a   Nakatani, Tatsuya ^a   Wada, Seiji ^a   Kishimoto, Taketoshi ^a   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; Cyclin D1; p21WAF1 Cip1; p53; Renal pelvis

Indexed keywords

CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; PROTEIN P53;

ADENOCARCINOMA; ARTICLE; CASE REPORT; CHEMISTRY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, TRANSITIONAL CELL; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; KIDNEY PELVIS; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032015573     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.3.227     Document Type: Article

References (10)

1. Kim YIL, Yoon DH, Lee SW, Lee C. Multicentric papillary adenocarcinoma of the renal pelvis and ureter. Cancer 1988;62:2402-7.
2. Mostofi FK, Davis CJ Jr, Sesternhenn IA. Pathology of tumors of the urinary tract. In: Skinner DG and Lieskovsky F. editors. Diagnosis and Management of Genitourinary Cancer. Philadelphia: W.B. Saunders. 1988;83-117.
3. Ashley DJB, Hickey BB. Adenocarcinoma of the renal pelvis. Br J Urol 1964;36:309-12.
4. Grabstald H, Whirmore WF, Melamed MR. Renal pelvic tumors. JAMA 1971;218:845-54.
5. Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, Ikemoto S, et al. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 1997;79:780-9.
6. Yamamoto S, Masui T, Murai T, Mon S, Oohara T, Makino S, et al Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl(4-hydroxybutyl)nitrosamine Carcinogenesis 1995;16:2363-8
7. Esrig D, Spruck CH III, Nichols P, Chaiwun B, Steven K, Groshen S, et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. AJP 1993;143:1389-97.
8. WAF1/Cip1 complexed with human PCNA Cell 1996;87:297-306.
9. Cip1. Nature 1995;375:159-61.
10. Mostofi FK. Potentialities of bladder epithelium. J Urol 1954;71:705-14